{"id":3022,"date":"2021-10-05T14:25:37","date_gmt":"2021-10-05T03:25:37","guid":{"rendered":"https:\/\/www.dalgarnoinstitute.org.au\/wp_site\/another-level-race-on-to-get-over-the-counter-cannabis-meds-to-pharmacies\/"},"modified":"2025-11-12T21:00:31","modified_gmt":"2025-11-12T10:00:31","slug":"another-level-race-on-to-get-over-the-counter-cannabis-meds-to-pharmacies","status":"publish","type":"post","link":"https:\/\/www.dalgarnoinstitute.org.au\/wp_site\/another-level-race-on-to-get-over-the-counter-cannabis-meds-to-pharmacies\/","title":{"rendered":"\u2018Another level\u2019: Race on to get over-the-counter cannabis meds to pharmacies"},"content":{"rendered":"

By Emma Koehn<\/a> <\/strong>September 2021<\/p>\n

ASX-listed cannabis companies are racing to get low-dose medicinal pot products onto shelves, with hopes they will be available through pharmacies by the end of next year.<\/p>\n

In February, the country\u2019s medicines regulator – the Therapeutic Goods Administration (TGA) – agreed to change the classification for certain products containing small amounts of cannabidiol (CBD), an active ingredient in the cannabis plant that does not get the user high but is used in therapeutic products.<\/p>\n

Under the new rules, cannabis medicines in this category are classified as \u201cschedule 3\u201d medicines and can be sold in pharmacies without the need for a prescription. However, no Australian products currently fit the criteria for an over-the-counter medicine, meaning drug developers must set up clinical trials for new products and show that they work before anything can be sold to consumers.<\/p>\n

\u201cThe interest in medicinal cannabis is strong, and it continues to grow,\u201d said chief executive of ASX-listed cannabis company Cann Group, Peter Crock.<\/p>\n

\u201cThe schedule 3 [pharmacy] product is going to take things to another level.\u201d<\/p>\n

The TGA says there is scientific evidence to support the use of CBD capsules to treat chronic pain, anxiety and sleep issues, but any over-the-counter medicines will have to provide robust evidence that they work for one particular ailment.<\/p>\n

For complete article <\/a><\/p>\n

Also Read<\/p>\n